Insider: Rodman David Malcom Chief Medical Officer - Mineralys Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 76,140 | 0 | 76,140 |
| Value | $1,997,913.60 | $0.00 | $1,997,913.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/17/2026 | DDS | 417 | Direct | COM | $25.65 | $10,696.05 | 76,140 |
| 03/13/2026 | DDS | 3,079 | Direct | COM | $27.37 | $84,264.53 | 76,393 |
| 03/13/2026 | DDS | 10,726 | Direct | COM | $25.91 | $277,922.46 | 79,472 |
| 03/13/2026 | DDS | 253 | Direct | COM | $27.82 | $7,038.46 | 76,140 |
| 03/12/2026 | DDS | 6,348 | Direct | COM | $27.37 | $173,747.93 | 82,489 |
| 03/09/2026 | DDS | 2,171 | Direct | COM | $26.84 | $58,269.64 | 82,489 |
| 02/17/2026 | DDS | 417 | Direct | COM | $27.59 | $11,505.03 | 44,089 |
| 02/13/2026 | DDS | 3,541 | Direct | COM | $27.33 | $96,775.53 | 50,437 |
| 02/13/2026 | DDS | 4,166 | Direct | COM | $27.33 | $113,856.78 | 50,437 |
| 02/13/2026 | DDS | 6,348 | Direct | COM | $27.58 | $175,100.06 | 44,089 |
| 02/12/2026 | DDS | 5,828 | Direct | COM | $28.94 | $168,634.93 | 50,958 |
| 02/12/2026 | DDS | 521 | Direct | COM | $29.64 | $15,441.76 | 50,437 |
| 02/09/2026 | DDS | 2,171 | Direct | COM | $30.21 | $65,585.91 | 50,437 |
| 01/20/2026 | DDS | 416 | Direct | COM | $32.10 | $13,353.60 | 50,437 |
| 01/14/2026 | DDS | 11,367 | Direct | COM | $32.61 | $370,644.91 | 50,437 |
| 01/13/2026 | DDS | 7,709 | Direct | COM | $32.75 | $252,469.75 | 61,804 |
| 01/12/2026 | DDS | 6,348 | Direct | COM | $32.32 | $205,143.24 | 61,804 |
| 01/09/2026 | DDS | 2,170 | Direct | COM | $33.27 | $72,195.90 | 61,804 |
| 01/05/2026 | DDS | 139,245 | Direct | COM | $34.83 | $4,849,555.24 | 115,274 |
| 01/05/2026 | DDS | 53,470 | Direct | COM | $35.53 | $1,899,553.83 | 61,804 |
| 01/02/2026 | DDS | 70,037 | Direct | COM | $35.87 | $2,511,919.03 | 69,188 |
| 10/15/2025 | DDS | 10,369 | Direct | COM | $43.01 | $445,982.10 | 71,155 |
| 09/15/2025 | DDS | 9,302 | Direct | COM | $35.90 | $333,945.52 | 83,589 |
| 09/15/2025 | DDS | 2,065 | Direct | COM | $36.47 | $75,320.46 | 81,524 |
| 08/13/2025 | DDS | 11,365 | Direct | COM | $12.93 | $146,986.95 | 92,891 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research